年轻患者导管内乳头状黏液性肿瘤的手术治疗:高风险人群
结果显示术后严重并发症(Clavien-Dindo≥III)18%,中位随访72个月,恶性IPMN相关癌复发率19%,良性IPMN复发率3%。结论认为年轻IPMN患者手术安全、并发症低且无围术期死亡,但恶性率高达45%,属高风险人群,对预期寿命长者可考虑预防性手术,术后需定期临床和影像学随访。
要点
- ≤50岁IPMN患者术后恶性率高达45%,属高风险人群。
- 年轻患者IPMN手术安全,严重并发症18%,无围术期死亡。
- 恶性IPMN术后相关癌复发率19%,需定期影像学随访。
核心结论
- 年轻IPMN患者手术安全、并发症低且无围术期死亡,但恶性率高,属高风险人群,可考虑预防性手术并定期随访。
主要发现
- 严重术后并发症(Clavien-Dindo≥III)14例(18%),中位住院时间10天,无围术期死亡。
- 中位随访72个月,恶性IPMN患者中6例(19%)出现IPMN相关癌复发,良性IPMN患者中1例(3%)复发。
关键数值与推荐
- 恶性率45%,严重并发症18%,中位住院10天,中位随访72个月,恶性IPMN复发19%,良性IPMN复发3%。
临床怎么用
- 对≤50岁IPMN患者,尤其预期寿命长者,可考虑预防性手术,术后定期临床和影像学随访以排除复发。
局限性
- 单中心回顾性分析,样本量有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraductal papillary mucinous neoplasms of the pancreas are uncommon in young individuals. Management of these patients is challenging because the risk of malignancy and recurrence after surgery remains unclear. The aim of the present study was to assess the long-term risk for intraductal papillary mucinous neoplasm recurrence after surgery for intraductal papillary mucinous neoplasms in patients ≤50 years of age. METHODS: Perioperative and long-term follow-up data of patients who had undergone surgery for intraductal papillary mucinous neoplasms between 2004 and 2020 were extracted from a prospective unicentric database and retrospectively analyzed. RESULTS: Seventy-eight patients underwent surgical treatment for benign intraductal papillary mucinous neoplasms (low-grade n = 22 and intermediate-grade n = 21) and malignant intraductal papillary mucinous neoplasms (high-grade n = 16 and intraductal papillary mucinous neoplasm-associated carcinoma n = 19). Severe postoperative morbidity (Clavien-Dindo ≥III) was found in 14 patients (18%). The median length of hospital stay was 10 days. No perioperative mortality was observed. The median length of follow-up was 72 months. Recurrence of intraductal papillary mucinous neoplasm-associated carcinoma was found in 6 patients (19%) with malignant intraductal papillary mucinous neoplasm and 1 patient (3%) with benign intraductal papillary mucinous neoplasm. CONCLUSION: Surgery for intraductal papillary mucinous neoplasm is safe and can be performed with low morbidity and potentially no mortality in young patients. Given the high rate of malignancy (45%), these patients with intraductal papillary mucinous neoplasms represent a high-risk population, and prophylactic surgical treatment should be considered in these patients with long life expectancies. Regular clinical and radiologic follow-up examinations are important to rule out disease recurrence, which is high, especially in patients with intraductal papillary mucinous neoplasm-associated carcinoma.
引用
- Kaiser J, Hackert T, Hinz U, et al. Surgery for intraductal papillary mucinous neoplasms in young patients: High-risk population. Surgery. 2023. PMID: 37225560. doi:10.1016/j.surg.2023.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。